Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anticoagulants Market 2018, Forecast to 2023

Publisher Name :
Date: 11-Jul-2018
No. of pages: 132

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Scope of the Report:

This report focuses on the Anticoagulants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.

Anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of anticoagulants used to treat AF, and the revenue in 2016 is 13118 M USD.

Europe region is the largest supplier of anticoagulants, with a production market share nearly 56.40% in 2016. North America is the second largest supplier of anticoagulants, enjoying production market share nearly 26.35% in 2016.

The worldwide market for Anticoagulants is expected to grow at a CAGR of roughly 8.8% over the next five years, will reach 1230 million US$ in 2023, from 740 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Bayer

- Boehringer Ingelheim

- Johnson & Johnson

- Genentech (Roche)

- AstraZeneca

- Bristol-Myers Squibb

- Aspen

- Lilly

- Otsuka

- Pfizer

- Daiichi Sankyo

- The Medicines Company

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Platelet aggregation inhibitors (PAI)

- Low-molecular-weight Heparin (LMWH)

- Direct thrombin inhibitor (DTI)

- Direct factor Xa inhibitors (DFXa)

- Vitamin K antagonists (VKA)

- Others

Market Segment by Applications, can be divided into

- VTE

- ACS/MI

- AF

- Other

There are 15 Chapters to deeply display the global Anticoagulants market.

Chapter 1, to describe Anticoagulants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anticoagulants, with sales, revenue, and price of Anticoagulants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anticoagulants, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anticoagulants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anticoagulants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Anticoagulants Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Anticoagulants Introduction
1.2 Market Analysis by Type
1.2.1 Platelet aggregation inhibitors (PAI)
1.2.2 Low-molecular-weight Heparin (LMWH)
1.2.3 Direct thrombin inhibitor (DTI)
1.2.4 Direct factor Xa inhibitors (DFXa)
1.2.5 Vitamin K antagonists (VKA)
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.1.1 Sanofi Description
2.1.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.1.2 Sanofi Anticoagulants Product Introduction
2.1.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.1.2.2 Anticoagulants Product Information
2.1.3 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Sanofi Anticoagulants Market Share in 2017
2.2 Bayer
2.2.1 Business Overview
2.2.1.1 Bayer Description
2.2.1.2 Bayer Headquarter, Main Business and Finance Overview
2.2.2 Bayer Anticoagulants Product Introduction
2.2.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.2.2.2 Anticoagulants Product Information
2.2.3 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Bayer Anticoagulants Market Share in 2017
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.1.1 Boehringer Ingelheim Description
2.3.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
2.3.2 Boehringer Ingelheim Anticoagulants Product Introduction
2.3.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.3.2.2 Anticoagulants Product Information
2.3.3 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Boehringer Ingelheim Anticoagulants Market Share in 2017
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.1.1 Johnson & Johnson Description
2.4.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.4.2 Johnson & Johnson Anticoagulants Product Introduction
2.4.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.4.2.2 Anticoagulants Product Information
2.4.3 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Johnson & Johnson Anticoagulants Market Share in 2017
2.5 Genentech (Roche)
2.5.1 Business Overview
2.5.1.1 Genentech (Roche) Description
2.5.1.2 Genentech (Roche) Headquarter, Main Business and Finance Overview
2.5.2 Genentech (Roche) Anticoagulants Product Introduction
2.5.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.5.2.2 Anticoagulants Product Information
2.5.3 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Genentech (Roche) Anticoagulants Market Share in 2017
2.6 AstraZeneca
2.6.1 Business Overview
2.6.1.1 AstraZeneca Description
2.6.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.6.2 AstraZeneca Anticoagulants Product Introduction
2.6.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.6.2.2 Anticoagulants Product Information
2.6.3 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global AstraZeneca Anticoagulants Market Share in 2017
2.7 Bristol-Myers Squibb
2.7.1 Business Overview
2.7.1.1 Bristol-Myers Squibb Description
2.7.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
2.7.2 Bristol-Myers Squibb Anticoagulants Product Introduction
2.7.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.7.2.2 Anticoagulants Product Information
2.7.3 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Bristol-Myers Squibb Anticoagulants Market Share in 2017
2.8 Aspen
2.8.1 Business Overview
2.8.1.1 Aspen Description
2.8.1.2 Aspen Headquarter, Main Business and Finance Overview
2.8.2 Aspen Anticoagulants Product Introduction
2.8.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.8.2.2 Anticoagulants Product Information
2.8.3 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Aspen Anticoagulants Market Share in 2017
2.9 Lilly
2.9.1 Business Overview
2.9.1.1 Lilly Description
2.9.1.2 Lilly Headquarter, Main Business and Finance Overview
2.9.2 Lilly Anticoagulants Product Introduction
2.9.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.9.2.2 Anticoagulants Product Information
2.9.3 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Lilly Anticoagulants Market Share in 2017
2.10 Otsuka
2.10.1 Business Overview
2.10.1.1 Otsuka Description
2.10.1.2 Otsuka Headquarter, Main Business and Finance Overview
2.10.2 Otsuka Anticoagulants Product Introduction
2.10.2.1 Anticoagulants Production Bases, Sales Regions and Major Competitors
2.10.2.2 Anticoagulants Product Information
2.10.3 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Otsuka Anticoagulants Market Share in 2017
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Pfizer Anticoagulants Product Introduction
2.11.3 Pfizer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Daiichi Sankyo
2.12.1 Business Overview
2.12.2 Daiichi Sankyo Anticoagulants Product Introduction
2.12.3 Daiichi Sankyo Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 The Medicines Company
2.13.1 Business Overview
2.13.2 The Medicines Company Anticoagulants Product Introduction
2.13.3 The Medicines Company Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anticoagulants Market Competition, by Manufacturer
3.1 Global Anticoagulants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anticoagulants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anticoagulants Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anticoagulants Manufacturer Market Share in 2017
3.4.2 Top 5 Anticoagulants Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Anticoagulants Market Analysis by Regions
4.1 Global Anticoagulants Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulants Sales by Regions (2013-2018)
4.1.2 Global Anticoagulants Revenue by Regions (2013-2018)
4.2 North America Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Anticoagulants Sales, Revenue and Growth Rate (2013-2018)
5 North America Anticoagulants by Countries, Type, Application and Manufacturers
5.1 North America Anticoagulants Sales, Revenue and Market Share by Countries
5.1.1 North America Anticoagulants Sales by Countries (2013-2018)
5.1.2 North America Anticoagulants Revenue by Countries (2013-2018)
5.1.3 United States Anticoagulants Sales and Growth Rate (2013-2018)
5.1.4 Canada Anticoagulants Sales and Growth Rate (2013-2018)
5.1.5 Mexico Anticoagulants Sales and Growth Rate (2013-2018)
5.2 North America Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Anticoagulants Sales by Manufacturers (2016-2017)
5.2.2 North America Anticoagulants Revenue by Manufacturers (2016-2017)
5.3 North America Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Anticoagulants Sales and Sales Share by Type (2013-2018)
5.3.2 North America Anticoagulants Revenue and Revenue Share by Type (2013-2018)
5.4 North America Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Anticoagulants Sales and Sales Share by Application (2013-2018)
5.4.2 North America Anticoagulants Revenue and Revenue Share by Application (2013-2018)
6 Europe Anticoagulants by Countries, Type, Application and Manufacturers
6.1 Europe Anticoagulants Sales, Revenue and Market Share by Countries
6.1.1 Europe Anticoagulants Sales by Countries (2013-2018)
6.1.2 Europe Anticoagulants Revenue by Countries (2013-2018)
6.1.3 Germany Anticoagulants Sales and Growth Rate (2013-2018)
6.1.4 UK Anticoagulants Sales and Growth Rate (2013-2018)
6.1.5 France Anticoagulants Sales and Growth Rate (2013-2018)
6.1.6 Russia Anticoagulants Sales and Growth Rate (2013-2018)
6.1.7 Italy Anticoagulants Sales and Growth Rate (2013-2018)
6.2 Europe Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Anticoagulants Sales by Manufacturers (2016-2017)
6.2.2 Europe Anticoagulants Revenue by Manufacturers (2016-2017)
6.3 Europe Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Anticoagulants Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Anticoagulants Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Anticoagulants Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Anticoagulants Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Anticoagulants by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anticoagulants Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Anticoagulants Revenue by Countries (2013-2018)
7.1.3 China Anticoagulants Sales and Growth Rate (2013-2018)
7.1.4 Japan Anticoagulants Sales and Growth Rate (2013-2018)
7.1.5 Korea Anticoagulants Sales and Growth Rate (2013-2018)
7.1.6 India Anticoagulants Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Anticoagulants Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anticoagulants Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anticoagulants Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Anticoagulants Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Anticoagulants Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Anticoagulants Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Anticoagulants Revenue and Revenue Share by Application (2013-2018)
8 South America Anticoagulants by Countries, Type, Application and Manufacturers
8.1 South America Anticoagulants Sales, Revenue and Market Share by Countries
8.1.1 South America Anticoagulants Sales by Countries (2013-2018)
8.1.2 South America Anticoagulants Revenue by Countries (2013-2018)
8.1.3 Brazil Anticoagulants Sales and Growth Rate (2013-2018)
8.1.4 Argentina Anticoagulants Sales and Growth Rate (2013-2018)
8.1.5 Colombia Anticoagulants Sales and Growth Rate (2013-2018)
8.2 South America Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Anticoagulants Sales by Manufacturers (2016-2017)
8.2.2 South America Anticoagulants Revenue by Manufacturers (2016-2017)
8.3 South America Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Anticoagulants Sales and Sales Share by Type (2013-2018)
8.3.2 South America Anticoagulants Revenue and Revenue Share by Type (2013-2018)
8.4 South America Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Anticoagulants Sales and Sales Share by Application (2013-2018)
8.4.2 South America Anticoagulants Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Anticoagulants by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anticoagulants Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Anticoagulants Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Anticoagulants Sales and Growth Rate (2013-2018)
9.1.4 UAE Anticoagulants Sales and Growth Rate (2013-2018)
9.1.5 Egypt Anticoagulants Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Anticoagulants Sales and Growth Rate (2013-2018)
9.1.7 South Africa Anticoagulants Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Anticoagulants Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anticoagulants Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anticoagulants Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Anticoagulants Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Anticoagulants Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Anticoagulants Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Anticoagulants Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Anticoagulants Revenue and Revenue Share by Application (2013-2018)
10 Global Anticoagulants Market Segment by Type
10.1 Global Anticoagulants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Anticoagulants Sales and Market Share by Type (2013-2018)
10.1.2 Global Anticoagulants Revenue and Market Share by Type (2013-2018)
10.2 Platelet aggregation inhibitors (PAI) Sales Growth and Price
10.2.1 Global Platelet aggregation inhibitors (PAI) Sales Growth (2013-2018)
10.2.2 Global Platelet aggregation inhibitors (PAI) Price (2013-2018)
10.3 Low-molecular-weight Heparin (LMWH) Sales Growth and Price
10.3.1 Global Low-molecular-weight Heparin (LMWH) Sales Growth (2013-2018)
10.3.2 Global Low-molecular-weight Heparin (LMWH) Price (2013-2018)
10.4 Direct thrombin inhibitor (DTI) Sales Growth and Price
10.4.1 Global Direct thrombin inhibitor (DTI) Sales Growth (2013-2018)
10.4.2 Global Direct thrombin inhibitor (DTI) Price (2013-2018)
10.5 Direct factor Xa inhibitors (DFXa) Sales Growth and Price
10.5.1 Global Direct factor Xa inhibitors (DFXa) Sales Growth (2013-2018)
10.5.2 Global Direct factor Xa inhibitors (DFXa) Price (2013-2018)
10.6 Vitamin K antagonists (VKA) Sales Growth and Price
10.6.1 Global Vitamin K antagonists (VKA) Sales Growth (2013-2018)
10.6.2 Global Vitamin K antagonists (VKA) Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Anticoagulants Market Segment by Application
11.1 Global Anticoagulants Sales Market Share by Application (2013-2018)
11.2 VTE Sales Growth (2013-2018)
11.3 ACS/MI Sales Growth (2013-2018)
11.4 AF Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Anticoagulants Market Forecast (2018-2023)
12.1 Global Anticoagulants Sales, Revenue and Growth Rate (2018-2023)
12.2 Anticoagulants Market Forecast by Regions (2018-2023)
12.2.1 North America Anticoagulants Market Forecast (2018-2023)
12.2.2 Europe Anticoagulants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Anticoagulants Market Forecast (2018-2023)
12.2.4 South America Anticoagulants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Anticoagulants Market Forecast (2018-2023)
12.3 Anticoagulants Market Forecast by Type (2018-2023)
12.3.1 Global Anticoagulants Sales Forecast by Type (2018-2023)
12.3.2 Global Anticoagulants Market Share Forecast by Type (2018-2023)
12.4 Anticoagulants Market Forecast by Application (2018-2023)
12.4.1 Global Anticoagulants Sales Forecast by Application (2018-2023)
12.4.2 Global Anticoagulants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Anticoagulants Picture
Table Product Specifications of Anticoagulants
Figure Global Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Anticoagulants CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Anticoagulants by Types in 2017
Figure Platelet aggregation inhibitors (PAI) Picture
Table Major Manufacturers of Platelet aggregation inhibitors (PAI)
Figure Low-molecular-weight Heparin (LMWH) Picture
Table Major Manufacturers of Low-molecular-weight Heparin (LMWH)
Figure Direct thrombin inhibitor (DTI) Picture
Table Major Manufacturers of Direct thrombin inhibitor (DTI)
Figure Direct factor Xa inhibitors (DFXa) Picture
Table Major Manufacturers of Direct factor Xa inhibitors (DFXa)
Figure Vitamin K antagonists (VKA) Picture
Table Major Manufacturers of Vitamin K antagonists (VKA)
Figure Others Picture
Table Major Manufacturers of Others
Figure Anticoagulants Sales Market Share by Applications in 2017
Figure VTE Picture
Figure ACS/MI Picture
Figure AF Picture
Figure Other Picture
Figure United States Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure France Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure UK Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure China Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure India Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Anticoagulants Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Sanofi Anticoagulants Product
Table Sanofi Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Anticoagulants Sales Market Share in 2017
Figure Global Sanofi Anticoagulants Revenue Market Share in 2017
Table Bayer Headquarter, Established, Main Business and Finance Overview (2017)
Table Bayer Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Bayer Anticoagulants Product
Table Bayer Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bayer Anticoagulants Sales Market Share in 2017
Figure Global Bayer Anticoagulants Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Anticoagulants Product
Table Boehringer Ingelheim Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Anticoagulants Sales Market Share in 2017
Figure Global Boehringer Ingelheim Anticoagulants Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Anticoagulants Product
Table Johnson & Johnson Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Anticoagulants Sales Market Share in 2017
Figure Global Johnson & Johnson Anticoagulants Revenue Market Share in 2017
Table Genentech (Roche) Headquarter, Established, Main Business and Finance Overview (2017)
Table Genentech (Roche) Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Genentech (Roche) Anticoagulants Product
Table Genentech (Roche) Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Genentech (Roche) Anticoagulants Sales Market Share in 2017
Figure Global Genentech (Roche) Anticoagulants Revenue Market Share in 2017
Table AstraZeneca Headquarter, Established, Main Business and Finance Overview (2017)
Table AstraZeneca Anticoagulants Production Bases, Sales Regions and Major Competitors
Table AstraZeneca Anticoagulants Product
Table AstraZeneca Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AstraZeneca Anticoagulants Sales Market Share in 2017
Figure Global AstraZeneca Anticoagulants Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Anticoagulants Product
Table Bristol-Myers Squibb Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Anticoagulants Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Anticoagulants Revenue Market Share in 2017
Table Aspen Headquarter, Established, Main Business and Finance Overview (2017)
Table Aspen Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Aspen Anticoagulants Product
Table Aspen Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aspen Anticoagulants Sales Market Share in 2017
Figure Global Aspen Anticoagulants Revenue Market Share in 2017
Table Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Lilly Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Lilly Anticoagulants Product
Table Lilly Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lilly Anticoagulants Sales Market Share in 2017
Figure Global Lilly Anticoagulants Revenue Market Share in 2017
Table Otsuka Headquarter, Established, Main Business and Finance Overview (2017)
Table Otsuka Anticoagulants Production Bases, Sales Regions and Major Competitors
Table Otsuka Anticoagulants Product
Table Otsuka Anticoagulants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Otsuka Anticoagulants Sales Market Share in 2017
Figure Global Otsuka Anticoagulants Revenue Market Share in 2017
Table Pfizer
Table Pfizer Anticoagulants
Table Daiichi Sankyo
Table Daiichi Sankyo Anticoagulants
Table The Medicines Company
Table The Medicines Company Anticoagulants
Table Global Anticoagulants Sales by Manufacturer (2016-2017)
Figure Global Anticoagulants Sales Market Share by Manufacturer in 2016
Figure Global Anticoagulants Sales Market Share by Manufacturer in 2017
Table Global Anticoagulants Revenue by Manufacturer (2016-2017)
Figure Global Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure Global Anticoagulants Revenue Market Share by Manufacturer in 2017
Table Global Anticoagulants Price by Manufacturer (2016-2017)
Figure Top 3 Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Anticoagulants Manufacturer (Revenue) Market Share in 2017
Figure Global Anticoagulants Sales and Growth Rate (2013-2018)
Figure Global Anticoagulants Revenue and Growth Rate (2013-2018)
Table Global Anticoagulants Sales by Regions (2013-2018)
Table Global Anticoagulants Sales Market Share by Regions (2013-2018)
Table Global Anticoagulants Revenue by Regions (2013-2018)
Figure Global Anticoagulants Revenue Market Share by Regions in 2013
Figure Global Anticoagulants Revenue Market Share by Regions in 2017
Figure North America Anticoagulants Sales and Growth Rate (2013-2018)
Figure North America Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Europe Anticoagulants Sales and Growth Rate (2013-2018)
Figure Europe Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Anticoagulants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Anticoagulants Revenue and Growth Rate (2013-2018)
Figure South America Anticoagulants Sales and Growth Rate (2013-2018)
Figure South America Anticoagulants Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Anticoagulants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Anticoagulants Revenue and Growth Rate (2013-2018)
Figure North America Anticoagulants Revenue and Growth Rate (2013-2018)
Table North America Anticoagulants Sales by Countries (2013-2018)
Table North America Anticoagulants Sales Market Share by Countries (2013-2018)
Figure North America Anticoagulants Sales Market Share by Countries in 2013
Figure North America Anticoagulants Sales Market Share by Countries in 2017
Table North America Anticoagulants Revenue by Countries (2013-2018)
Table North America Anticoagulants Revenue Market Share by Countries (2013-2018)
Figure North America Anticoagulants Revenue Market Share by Countries in 2013
Figure North America Anticoagulants Revenue Market Share by Countries in 2017
Figure United States Anticoagulants Sales and Growth Rate (2013-2018)
Figure Canada Anticoagulants Sales and Growth Rate (2013-2018)
Figure Mexico Anticoagulants Sales and Growth Rate (2013-2018)
Table North America Anticoagulants Sales by Manufacturer (2016-2017)
Figure North America Anticoagulants Sales Market Share by Manufacturer in 2016
Figure North America Anticoagulants Sales Market Share by Manufacturer in 2017
Table North America Anticoagulants Revenue by Manufacturer (2016-2017)
Figure North America Anticoagulants Revenue Market Share by Manufacturer in 2016
Figure North America Anticoagulants Revenue Market Share by Manufacturer in 2017
Table North America Anticoagulants Sales by Type (2013-2018)
Table North America Anticoagulants Sales Share by Type (2013-2018)
Table North America Anticoagulants Revenue by Type (2013-2018)
Table North America Anticoagulants Revenue Share by Type (2013-2018)
Table North America Anticoagulants Sales by Application (2013-2018)
Table North America Anticoagulants Sales Share by Application (2013-2018)
Table North America Anticoagulants Revenue by Application (2013-2018)
Table North America Anticoagulants Revenue Share by Application (2013-2018)
Figure Europe Anticoagulants Revenue and Growth Rate (2013-2018)
Table Europe Anticoagulants Sales by Countries (2013-2018)
Table Europe Anticoagulants Sales Market Share by Countries (2013-2018)
Table Europe Anticoagulants Revenue by Countries (2013-2018)
Figure Europe Anticoagulants Revenue Market Share by Countries in 2016
Figure Europe Anticoagulants Revenue Market Share by Countries in 2017
Figure Germany Anticoagulants Sales and Growth Rate (2013-2018)
Figure UK Anticoagulants Sales and Growth Rate (2013-2018)
Figure France Anticoagulants Sales and Growt
  • Global Hemophilia Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Hemophilia is a hereditary genetic disorder which impairs body's ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development......
  • 2015-2023 World Hemophilia Treatment Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Sep-2018        Price: US 2800 Onwards        Pages: 81
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • 2015-2023 World Intravenous Immunoglobulins Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 17-Sep-2018        Price: US 2800 Onwards        Pages: 82
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • Global Intravenous Immunoglobulin (IVIg) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Sep-2018        Price: US 3480 Onwards        Pages: 134
    Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or "lot" of Intravenous Immunoglobulin. Scope of the Report: This report focuses on the Intravenous Immunoglobulin (IVIg) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report......
  • 2018-2023 India Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino......
  • Global Fibrinogen Concentrates Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 06-Sep-2018        Price: US 3480 Onwards        Pages: 117
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • 2018-2023 Philippines Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai......
  • 2018-2023 UK Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In UK market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinbai - Yino Pharm......
  • 2018-2023 United States Heparin Market Report (Status and Outlook)
    Published: 06-Sep-2018        Price: US 3360 Onwards        Pages: 83
    In 2017, the Heparin market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In United States market, the top players include - Hepalink - Changshan Pharm - Qianhong Bio-pharma - Opocrin - Pfizer - Aspen Oss - King-friend Biochemical Pharmaceutical - Bioibérica - Dongcheng Biochemicals - Jiulong Biochemicals - Tiandong - Xinb......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs